End-to-End Registration Timeline for Medical Devices in Thailand

How long does the whole Thai registration process take? Two concepts must be distinguished: the review time limits and the full project timeline. The review limits are set by class; the project timeline is dominated by what happens before submission, not by the review itself.

1. Key takeaways

The main variable in a real project timeline lies in the front end (establishment licence, localisation and dossier), not in the review stage. The phase map and the compression levers follow.

• Phase magnitudes: establishment licence (including site preparation and inspection) is a front-end item whose scheduling is not controllable; CSDT dossier compilation takes weeks to months depending on documentation readiness; Thai-language localisation (labels and IFU for home-use devices) runs in parallel, usually weeks to months; e-Submission completeness check takes about 15 days; substantive review has official ceilings of 200 / 250 / 300 days for Class 1 / 2-3 / 4; the Reliance (HSA) route takes 60 working days; Class 1 Positive List devices receive auto-approval.
• Four activities consume the most project time: the establishment licence site inspection — scheduling is uncontrollable and it is a precondition for product registration; the first writing of the CSDT — especially the risk management, verification and validation summary, Essential Principles and clinical evaluation sections; Thai-language localisation — home-use device labels and IFU must be in Thai, and translation quality affects review; and deficiency round-trips — each round-trip resets part of the clock.
• Five compression paths: start the establishment licence earliest (the only front-end item containing an incompressible site inspection); run Thai localisation and dossier compilation in parallel, never in series; assess accelerated pathways — approvals from the Singapore HSA or Malaysian MDA allow the no-holding-period reliance programmes, while approvals from the US FDA, an EU notified body, the TGA, Health Canada or the Japanese MHLW held for at least 1 year allow the Abridged route; use grouping strategy to dilute unit cost, since fees are charged per application (article 16); and get it right the first time — build to the Full base and subtract per route to reduce deficiency rounds.
• Start dates working backwards from the target launch date: Class 4 standard route: 12-18 months before launch; Class 2/3 standard route: 9-12 months; Reliance or Abridged: 6-9 months; Class 1 (outside the Positive List): 4-6 months.
• If wireless functions are involved (NBTC approval required, 30-45 working days) or sterile / measuring functions (additional sterilisation or calibration reports needed), add the corresponding scheduling on top of the above.

2. Legal basis

The phase structure follows the Thai FDA website process For Commercial Purpose, Steps 1-7; the completeness-check duration (about 15 days) and the review ceilings (Class 1: 200 days, Class 2-3: 250 days, Class 4: 300 days) are the officially listed limits; the HSA Reliance route rests on the reliance announcement of June 4, 2024 (B.E. 2567) and runs to 60 working days; Class 1 auto-approval rests on the January 2025 Positive List announcement; wireless approval by the NBTC takes 30-45 working days; and the MoPH labelling notification B.E. 2568 (2025) provides a 120-day grace period for affixing Thai-language labelling. The phase map is summarised below.

3. Expert insights

When scheduling for Thailand, the two items to run in parallel and start earliest are the establishment licence site inspection and Thai-language localisation, because they are more likely to become the bottleneck than the review itself. The site inspection cannot be compressed and gates the product registration; localisation is a hard requirement for home-use devices and its quality feeds back into review outcomes. Review, by contrast, generally runs faster than its published ceilings, and the deficiency rounds that consume months are largely a function of dossier quality rather than class. The planning implication: a schedule built around review days alone will systematically mispredict real project duration.

The robust scheduling model is the three-stage structure: front-end (establishment licence + localisation) + review + deficiency buffer. GRZAN prepares client schedules uniformly on this three-stage basis and specifies the responsibility split for each stage in the contract, so that delays of the kind where one party waits for the other’s materials cannot arise without an attributable owner.

4. Practical recommendations

• Plan backwards from the target launch date: 12-18 months for Class 4 standard route, 9-12 months for Class 2/3, 6-9 months for Reliance or Abridged, 4-6 months for Class 1 outside the Positive List.
• Add NBTC scheduling (30-45 working days) for wireless functions and additional report preparation for sterile or measuring devices on top of the base dates.
• Start the establishment licence first — it contains the only incompressible step, the site inspection.
• Run Thai localisation in parallel with dossier compilation, never in sequence.
• Use the three-stage schedule model — front-end + review (about 60 percent of the class ceiling as a working estimate) + one deficiency buffer — instead of a single number.
• Apply the grouping strategy to dilute official fees, since they are charged per application rather than per device.
• Build the dossier to the Full base and subtract for the chosen route, so deficiency rounds stay minimal and route changes do not restart the work.
• Fix stage-by-stage responsibilities in the project contract to keep every delay attributable.

5. Verification checklist

• □ Thai FDA website For Commercial Purpose full process, Steps 1-7
• □ e-Submission completeness check of about 15 days
• □ Review ceilings: Class 1 200 days / Class 2-3 250 days / Class 4 300 days
• □ HSA Reliance 60 working days
• □ Class 1 auto-approval (January 2025)
• □ NBTC approval (30-45 working days)
• □ MoPH labelling notification B.E. 2568 (2025): 120-day grace period for affixing

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support across Southeast Asia, including Thailand. Our team prepares dossiers to ASEAN CSDT structure, manages submissions and deficiency responses with the Thai FDA, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com